Xeris Biopharma Holdings (XERS) Accumulated Expenses (2020 - 2026)
Xeris Biopharma Holdings (XERS) recorded Accumulated Expenses of $39.71 million in Q2 2026, up 59.0% from $24.97 million a year earlier and up 23.0% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Xeris Biopharma Holdings reported Accumulated Expenses of $33.16 million, up 19.6% from FY2024.
- Annual Accumulated Expenses has a five-year compound annual growth rate of 15.8% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $27.72 million in FY2024 (+17.9%), $23.51 million in FY2023 (-36.1%), $36.79 million in FY2022 (-25.1%) and $49.09 million in FY2021 (+208.8%).
- The Q2 2026 figure is the highest quarterly Accumulated Expenses since Q4 2021.
- On a year-over-year basis, Accumulated Expenses has increased for five consecutive quarters, with growth averaging 25.7% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 208.8% in Q4 2021, against a decline of 49.4% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $32.29 million (Q1 2026), $33.16 million (Q4 2025) and $30.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 47.37 Mn |
| Jun 30, 2026 | 39.71 Mn |
| Mar 31, 2026 | 32.29 Mn |
| Dec 31, 2025 | 33.16 Mn |
| Sep 30, 2025 | 30.35 Mn |
| Jun 30, 2025 | 24.97 Mn |
| Mar 31, 2025 | 20.05 Mn |
| Dec 31, 2024 | 27.72 Mn |
| Sep 30, 2024 | 23.54 Mn |
| Jun 30, 2024 | 23.49 Mn |
| Mar 31, 2024 | 22.39 Mn |
| Dec 31, 2023 | 23.51 Mn |
| Sep 30, 2023 | 19.07 Mn |
| Jun 30, 2023 | 19.41 Mn |
| Mar 31, 2023 | 20.15 Mn |
| Dec 31, 2022 | 36.79 Mn |
| Sep 30, 2022 | 37.71 Mn |
| Jun 30, 2022 | 36.95 Mn |
| Mar 31, 2022 | 34.36 Mn |
| Dec 31, 2021 | 49.09 Mn |
API Access
Xeris Biopharma Holdings Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();